Azamian Bobak R., President, CEO, and Board Chair of Tarsus Pharmaceuticals ($TARS), sold shares on the open market eight times over the past year, totaling $2.59 million. His most recent sale occurred on December 24, 2025. These sales rank 2,979th among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions per insider. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 11964 | $67.00 | 891,412.0000 | 42,607,717 | 1.32% | 0.03% |
| March 18, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 11667 | $68.71 | 903,376.0000 | 42,607,717 | 1.28% | 0.03% |
| March 17, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 10972 | $69.42 | 915,043.0000 | 42,607,717 | 1.18% | 0.03% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 23121 | $0.00 | 46,243.0000 | 42,607,717 | 33.33% | 0.05% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 11300 | $0.00 | 0.0000 | 42,607,717 | 100.00% | 0.03% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 14878 | $0.00 | 44,634.0000 | 42,607,717 | 25.00% | 0.03% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Common Stock | 66274 | $0.00 | 926,015.0000 | 42,607,717 | 7.71% | 0.16% |
| March 15, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 16975 | $0.00 | 16,975.0000 | 42,607,717 | 50.00% | 0.04% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Restricted Stock Units | 60776 | $0.00 | 60,776.0000 | 42,607,717 | 9999.99% | 0.14% |
| March 5, 2026 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Stock Option (right to buy) | 96723 | $0.00 | 96,723.0000 | 42,607,717 | 9999.99% | 0.23% |
| Dec. 24, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 557 | $83.54 | 859,741.0000 | 42,607,717 | 0.06% | 0.00% |
| Dec. 24, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 5443 | $82.41 | 860,298.0000 | 42,607,717 | 0.63% | 0.01% |
| Dec. 4, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | G | Common Stock | 51885 | $0.00 | 865,741.0000 | 42,607,717 | 5.65% | 0.12% |
| Sept. 24, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 6000 | $55.37 | 865,741.0000 | 37,604,538 | 0.69% | 0.02% |
| Aug. 11, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 6000 | $50.00 | 871,741.0000 | 37,604,538 | 0.68% | 0.02% |
| March 24, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 6000 | $50.00 | 877,741.0000 | 37,604,538 | 0.68% | 0.02% |
| March 20, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8534 | $50.11 | 883,741.0000 | 37,604,538 | 0.96% | 0.02% |
| March 18, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 7131 | $46.29 | 900,826.0000 | 37,604,538 | 0.79% | 0.02% |
| March 19, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8551 | $47.40 | 892,275.0000 | 37,604,538 | 0.95% | 0.02% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Common Stock | 51395 | $0.00 | 907,957.0000 | 37,604,538 | 6.00% | 0.14% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 11299 | $0.00 | 11,300.0000 | 37,604,538 | 50.00% | 0.03% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 16975 | $0.00 | 33,950.0000 | 37,604,538 | 33.33% | 0.05% |
| March 15, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 23121 | $0.00 | 69,364.0000 | 37,604,538 | 25.00% | 0.06% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Restricted Stock Units | 59512 | $0.00 | 59,512.0000 | 37,604,538 | 9999.99% | 0.16% |
| March 5, 2025 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Stock Option (right to buy) | 90736 | $0.00 | 90,736.0000 | 37,604,538 | 9999.99% | 0.24% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 16975 | $0.00 | 50,925.0000 | 29,383,276 | 25.00% | 0.06% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 11299 | $0.00 | 22,599.0000 | 29,383,276 | 33.33% | 0.04% |
| March 18, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 10415 | $30.60 | 856,562.0000 | 29,383,276 | 1.20% | 0.04% |
| March 15, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Common Stock | 28274 | $0.00 | 866,977.0000 | 29,383,276 | 3.37% | 0.10% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Restricted Stock Units | 92485 | $0.00 | 92,485.0000 | 29,383,276 | 9999.99% | 0.31% |
| March 7, 2024 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Stock Option (right to buy) | 136947 | $0.00 | 136,947.0000 | 29,383,276 | 9999.99% | 0.47% |
| Dec. 27, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $20.22 | 838,703.0000 | 24,619,700 | 0.94% | 0.03% |
| Dec. 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 30557 | $20.36 | 846,703.0000 | 24,619,700 | 3.48% | 0.12% |
| Dec. 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 9443 | $19.96 | 877,260.0000 | 24,619,700 | 1.06% | 0.04% |
| Nov. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 200 | $19.28 | 886,703.0000 | 24,619,700 | 0.02% | 0.00% |
| Nov. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 4904 | $18.54 | 886,903.0000 | 24,619,700 | 0.55% | 0.02% |
| Nov. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 2896 | $18.01 | 891,807.0000 | 24,619,700 | 0.32% | 0.01% |
| Oct. 18, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $13.24 | 894,703.0000 | 24,619,700 | 0.89% | 0.03% |
| Sept. 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $17.21 | 902,703.0000 | 24,619,700 | 0.88% | 0.03% |
| Aug. 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $17.23 | 910,703.0000 | 24,619,700 | 0.87% | 0.03% |
| July 19, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 4174 | $19.28 | 1,018,429.0000 | 24,619,700 | 0.41% | 0.02% |
| July 19, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 99726 | $20.04 | 918,703.0000 | 24,619,700 | 9.79% | 0.41% |
| July 12, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 9000 | $17.35 | 1,022,603.0000 | 24,619,700 | 0.87% | 0.04% |
| June 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $18.63 | 1,031,603.0000 | 24,619,700 | 0.77% | 0.03% |
| June 14, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 9000 | $18.58 | 1,039,603.0000 | 24,619,700 | 0.86% | 0.04% |
| June 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 3100 | $20.01 | 1,041,756.0000 | 24,619,700 | 0.30% | 0.01% |
| May 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $15.90 | 1,051,703.0000 | 24,619,700 | 0.75% | 0.03% |
| May 10, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 9000 | $16.80 | 1,059,703.0000 | 24,619,700 | 0.84% | 0.04% |
| April 28, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 4278 | $15.13 | 1,074,544.0000 | 24,619,700 | 0.40% | 0.02% |
| May 1, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 5841 | $15.10 | 1,068,703.0000 | 24,619,700 | 0.54% | 0.02% |
| April 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 2311 | $15.03 | 1,078,822.0000 | 24,619,700 | 0.21% | 0.01% |
| April 19, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $13.60 | 1,081,133.0000 | 24,619,700 | 0.73% | 0.03% |
| March 22, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 709 | $12.64 | 1,089,870.0000 | 24,619,700 | 0.07% | 0.00% |
| March 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 737 | $12.15 | 1,089,133.0000 | 24,619,700 | 0.07% | 0.00% |
| March 21, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 679 | $12.89 | 1,090,579.0000 | 24,619,700 | 0.06% | 0.00% |
| March 17, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 795 | $13.28 | 1,091,999.0000 | 24,619,700 | 0.07% | 0.00% |
| March 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 741 | $12.61 | 1,091,258.0000 | 24,619,700 | 0.07% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Common Stock | 11299 | $0.00 | 1,093,585.0000 | 24,619,700 | 1.04% | 0.05% |
| March 16, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 791 | $13.43 | 1,092,794.0000 | 24,619,700 | 0.07% | 0.00% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | M | Restricted Stock Units | 11299 | $0.00 | 33,898.0000 | 24,619,700 | 25.00% | 0.05% |
| March 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $13.79 | 1,092,794.0000 | 24,619,700 | 0.73% | 0.03% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Restricted Stock Units | 67900 | $0.00 | 67,900.0000 | 24,619,700 | 9999.99% | 0.28% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 4853 | $15.02 | 1,091,003.0000 | 24,619,700 | 0.44% | 0.02% |
| March 9, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 717 | $15.01 | 1,090,286.0000 | 24,619,700 | 0.07% | 0.00% |
| March 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | A | Stock Option (right to buy) | 100242 | $0.00 | 100,242.0000 | 24,619,700 | 9999.99% | 0.41% |
| Feb. 15, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $15.28 | 1,095,856.0000 | 24,619,700 | 0.72% | 0.03% |
| Feb. 8, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 9000 | $15.14 | 1,103,856.0000 | 24,619,700 | 0.81% | 0.04% |
| Jan. 23, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 4856 | $15.45 | 1,112,856.0000 | 24,619,700 | 0.43% | 0.02% |
| Jan. 6, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 411 | $15.00 | 1,131,490.0000 | 24,619,700 | 0.04% | 0.00% |
| Jan. 18, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 8000 | $14.56 | 1,118,363.0000 | 24,619,700 | 0.71% | 0.03% |
| Jan. 20, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 240 | $15.00 | 1,118,123.0000 | 24,619,700 | 0.02% | 0.00% |
| Jan. 11, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 3904 | $15.11 | 1,126,363.0000 | 24,619,700 | 0.35% | 0.02% |
| Jan. 9, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 729 | $15.15 | 1,131,172.0000 | 24,619,700 | 0.06% | 0.00% |
| Jan. 10, 2023 | Tarsus Pharmaceuticals, Inc. | $TARS | Azamian Bobak R. | President/CEO and Board Chair | S | Common Stock | 905 | $15.17 | 1,130,267.0000 | 24,619,700 | 0.08% | 0.00% |